| |
| |
|
| Insider
Information: |
Or Yat Sun |
| Relationship: |
Chief Scientific Officer |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
373,295 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,061,880 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
373,295 |
|
|
| Total
Value |
$5,061,880 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 31.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enanta Pharmaceuticals Inc |
ENTA |
Chief Scientific Officer |
2024-02-12 |
373,295 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2024-02-12 |
4 |
D |
$12.41 |
$13,403 |
D/D |
(1,080) |
373,295 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,680 |
374,375 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP, R&D & CSO |
• – – |
2023-12-05 |
4 |
S |
$9.63 |
$23,228 |
D/D |
(2,412) |
370,695 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP, R&D & CSO |
• – – |
2023-12-01 |
4 |
D |
$9.49 |
$15,137 |
D/D |
(1,595) |
373,107 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2023-03-15 |
4 |
AS |
$43.92 |
$618,960 |
D/D |
(13,925) |
374,702 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2023-03-15 |
4 |
OE |
$14.00 |
$194,950 |
D/D |
13,925 |
388,627 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
23,267 |
382,454 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2023-02-13 |
4 |
D |
$52.77 |
$409,073 |
D/D |
(7,752) |
374,702 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2022-12-01 |
4 |
D |
$44.33 |
$46,768 |
D/D |
(1,055) |
359,187 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2022-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
360,242 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2022-02-14 |
4 |
D |
$62.49 |
$59,553 |
D/D |
(953) |
339,242 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2022-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,034 |
340,195 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2021-12-01 |
4 |
D |
$87.68 |
$48,838 |
D/D |
(557) |
337,161 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2021-01-26 |
4 |
OE |
$11.77 |
$173,576 |
D/D |
13,693 |
330,918 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2020-12-15 |
4 |
D |
$42.52 |
$65,481 |
D/D |
(1,540) |
317,225 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2020-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
318,765 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2020-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,600 |
313,515 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2020-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,412 |
307,004 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2020-02-12 |
4 |
D |
$52.76 |
$57,456 |
D/D |
(1,089) |
305,915 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2019-12-16 |
4 |
D |
$63.88 |
$148,904 |
D/D |
(2,331) |
303,592 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2019-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
305,923 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2019-03-01 |
4 |
AS |
$103.32 |
$1,035,320 |
D/D |
(10,000) |
300,673 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2019-02-12 |
4 |
D |
$88.88 |
$621,538 |
D/D |
(6,993) |
310,673 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
15,750 |
317,666 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Sr. VP & CSO |
• – – |
2019-02-12 |
4 |
AS |
$90.07 |
$567,173 |
D/D |
(6,297) |
301,916 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
